Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Mirum Pharmaceuticals, Inc. (MIRM)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 53,602,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Mirum Pharmaceuticals is a biopharmaceutical company focused on the identification, acquisition, development and commercialization of therapies for rare and orphan diseases. Co.'s focus is the development and commercialization of LIVMARLI® (maralixibat) oral solution (Livmarli) and volixibat. Livmarli is an oral solution approved as a once daily medicine for cholestatic pruritus in patients with Alagille syndrome one year of age and older. Co.'s second product candidate, volixibat, an oral, minimally-absorbed agent designed to inhibit ileal bile acid transporter, for the treatment of adult patients with cholestatic liver diseases.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 4,000 4,000 175,963 175,963
Total Buy Value $101,200 $101,200 $4,703,025 $4,703,025
Total People Bought 1 1 2 2
Total Buy Transactions 2 2 8 8
Total Shares Sold 4,303 26,974 69,916 431,922
Total Sell Value $111,017 $737,972 $1,983,116 $9,495,201
Total People Sold 1 5 6 8
Total Sell Transactions 1 12 21 30
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 191
  Page 4 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Odonnell Niall Director   –       •      –    2022-11-15 4 S $19.69 $1,846,022 I/I (93,770) 1,621,118     -
   Odonnell Niall Director   –       •      –    2022-11-14 4 S $19.60 $629,423 I/I (32,109) 1,714,888     -
   Odonnell Niall Director   –       •      –    2022-11-11 4 S $19.99 $3,481,410 I/I (174,121) 1,746,997     -
   Clements Ian Chief Financial Officer   •       –      –    2022-11-10 4 A $17.05 $5,542 D/D 325 30,011     -
   Vig Pamela Head of Research & Development   •       –      –    2022-11-10 4 A $17.05 $11,254 D/D 660 21,902     -
   Peetz Christopher President and CEO   •       •      –    2022-11-10 4 A $17.05 $835 D/D 49 69,576     -
   Longpre Lara Chief Development Officer   •       –      –    2022-11-10 4 A $17.05 $1,398 D/D 82 96,534     -
   Radovich Peter Chief Operating Officer   •       –      –    2022-11-10 4 A $17.05 $4,979 D/D 292 23,692     -
   Deerfield Healthcare Innovations Fund, L.p. * Possible Member of 10% Group   –       –       •   2022-06-06 4 S $24.47 $962,256 I/I (38,478) 1,540,190     -
   Radovich Peter Chief Operating Officer   •       –      –    2022-05-10 4 A $13.57 $15,859 D/D 1,169 23,400     -
   Longpre Lara Chief Development Officer   •       –      –    2022-05-10 4 A $13.57 $19,725 D/D 1,454 96,452     -
   Clements Ian Chief Financial Officer   •       –      –    2022-05-10 4 A $13.57 $15,262 D/D 1,125 29,686     -
   Vig Pamela Head of Research & Development   •       –      –    2022-05-10 4 A $13.57 $10,948 D/D 807 21,242     -
   Peetz Christopher President and CEO   •       •      –    2022-05-10 4 A $13.57 $20,349 D/D 1,500 69,527     -
   Peetz Christopher President and CEO   •       •      –    2022-01-06 4 A $0.00 $0 D/D 40,000 68,027     -
   Clements Ian Chief Financial Officer   •       –      –    2022-01-06 4 A $0.00 $0 D/D 10,000 28,561     -
   Radovich Peter Chief Operating Officer   •       –      –    2022-01-06 4 A $0.00 $0 D/D 10,000 22,231     -
   Vig Pamela Chief Scientific Officer   •       –      –    2022-01-06 4 A $0.00 $0 D/D 10,000 20,435     -
   Longpre Lara Chief Development Officer   •       –      –    2022-01-06 4 A $0.00 $0 D/D 10,000 94,998     -
   Clements Ian Chief Financial Officer   •       –      –    2021-11-26 4 B $13.90 $10,425 D/D 750 18,561 2.74     -
   Clements Ian Chief Financial Officer   •       –      –    2021-11-24 4 B $14.40 $10,080 D/D 700 17,811 2.74     -
   Vig Pamela Chief Scientific Officer   •       –      –    2021-11-10 4 A $13.52 $10,380 D/D 768 10,435     -
   Clements Ian Chief Financial Officer   •       –      –    2021-11-10 4 A $13.52 $6,190 D/D 458 17,111     -
   Tucker Edwin Jonathan Chief Medical Officer   •       –      –    2021-11-10 4 A $13.52 $946 D/D 70 45,838     -
   Radovich Peter Chief Operating Officer   •       –      –    2021-11-10 4 A $13.52 $12,947 D/D 958 12,231     -
  191 Records found
  1  2  3  4  5  6  7  8   
  Page 4 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us